The president received heavy criticism after claiming that injecting disinfectants could help treat COVID-19. WASHINGTON - U.S.
regulators on Friday allowed emergency use of an experimental drug that appears to help some coronavirus patients recover faster.
It is the first drug shown to help fight COVID-19, which has killed more than 230,000 people worldwide.RELATED: More than 1 million people have recovered globally from COVID-19, according to Johns Hopkins data The Food and Drug Administration acted after preliminary results from a government-sponsored study showed that Gilead Sciences’s remdesivir shortened the time to recovery by 31%, or about four days on average, for hospitalized COVID-19 patients.